1-6 of 6
Nils Winkelmann, MD
Close
Sort by
Journal Articles

Treosulfan, Fludarabine and Cytarabine As Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation

Inken Hilgendorf, MD, Nils Winkelmann, MD, Jochen J Frietsch, MD, Friederike Hunstig, MD, Ulf Schnetzke, MD, Sebastian Scholl, MD, Andreas Hochhaus, MD, Jochen Casper, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5702.
https://doi.org/10.1182/blood-2018-99-118259
Published: 2018
Journal Articles

Prevalence and Dynamics of BCR-ABL Independent Gene Mutations in Patients with Chronic Myeloid Leukemia

Thomas Ernst, MD, Jenny Rinke, Melinda Busch, Jana Ernst, MD, Ellen Obstfelder, Mathias Schmidt, MD, Vivien Schäfer, Anja Waldau, Nils Winkelmann, MD, Bernd Gruhn, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2016) 128 (22): 1221.
https://doi.org/10.1182/blood.V128.22.1221.1221
Published: 2016
Journal Articles

Molecularly Defined Clonal Evolution in Patients with Chronic Myeloid Leukemia Independent of the BCR-ABL Status

Thomas Ernst, MD, Mathias Schmidt, Jenny Rinke, Vivien Schäfer, Anja Waldau, Ellen Obstfelder, Nils Winkelmann, MD, Janine Ziermann, PhD, Susanne Schnittger, PhD, Torsten Haferlach, MD PhD, Claudia Haferlach, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2014) 124 (21): 4513.
https://doi.org/10.1182/blood.V124.21.4513.4513
Published: 2014
Journal Articles

Mutations In XPO1, POT1, BIRC3 and FBXW7 collectively Predict Poor Outcome At Diagnosis In CLL and MBL Independent From The SF3B1 and NOTCH1 Status

Nils Winkelmann, MD, Mathew J Rose-Zerilli, PhD, Jade Forster, Mathew Parry, PhD, Anton Parker, BSc, Anne Gardiner, Zadie Davies, BSC, Andrew J Steele, PhD, Helen Parker, PhD, Andrew Collins, PhD, Nick C.P. Cross, PhD, David Oscier, MD, Jonathan C Strefford
Journal: Blood
Blood (2013) 122 (21): 4138.
https://doi.org/10.1182/blood.V122.21.4138.4138
Published: 2013
Journal Articles

Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia Abrogate an Ubiquitination Site and Dysregulate SETBP1 Protein Levels

Carlo Gambacorti-Passerini, MD, Simona Valletta, Nils Winkelmann, MD, Sara Redaelli, PhD, Roberta Spinelli, M.Sc., Alessandra Pirola, M.Sc., Laura Antolini, Luca Mologni, PhD, Carla Donadoni, Elli Papaemmanuil, PhD, Susanne Schnittger, PhD, Kim Dong-Wook, Jacqueline Boultwood, MD, Fabio Rossi, Giuseppe Gaipa, PhD, Greta De Martini, MD, Paola Francia di Celle, PhD, Hyun G. Jang, Valeria Fantin, PhD, Graham R Bignell, Vera Magistroni, PhD, Torsten Haferlach, MD, Enrico Maria Pogliani, MD, Peter Campbell, MD Phd, Andrew J Chase, PhD, William J Tapper, PhD, Nicholas C.P. Cross, PhD, FRCPath, Rocco Piazza, MD, PhD
Journal: Blood
Blood (2012) 120 (21): LBA-2.
https://doi.org/10.1182/blood.V120.21.LBA-2.LBA-2
Published: 2012
Journal Articles

Inactivation of Polycomb Repressive Complex 2 Components in Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms

Nicholas C.P. Cross, PhD, FRCPath, Joannah Score, PhD, Claire Hidalgo-Curtis, PhD, Amy V Jones, PhD, Nils Winkelmann, MD, Alison Skinner, BSc, Daniel Ward, MSc, Katerina Zoi, MD, PhD, Thomas Ernst, MD, Frank Stegelmann, MD, Konstanze Dohner, MD, PhD, Andrew J Chase, PhD
Journal: Blood
Blood (2011) 118 (21): 617.
https://doi.org/10.1182/blood.V118.21.617.617
Published: 2011